ISTH 2026 Congress abstract: Marstacimab prophylaxis in pediatric participants with hemophilia A or B with or without inhibitors:
interim results from the phase 3 BASIS KIDS trial
ISTH 2026 Congress abstract: 5-Yearpost hoc end-of-study analysis of etranacogene
dezaparvovec in the phase 3 HOPE-B trial in patients with severe/moderately severe haemophilia B